Correlation Between Zymeworks Common and Jasper Therapeutics

Can any of the company-specific risk be diversified away by investing in both Zymeworks Common and Jasper Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zymeworks Common and Jasper Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zymeworks Common Stock and Jasper Therapeutics, you can compare the effects of market volatilities on Zymeworks Common and Jasper Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zymeworks Common with a short position of Jasper Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zymeworks Common and Jasper Therapeutics.

Diversification Opportunities for Zymeworks Common and Jasper Therapeutics

-0.67

Correlation Coefficient

Zymeworks Common  Jasper Therapeutics

Excellent diversification

The 3 months correlation between Zymeworks and Jasper is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Zymeworks Common Stock and Jasper Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jasper Therapeutics and Zymeworks Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zymeworks Common Stock are associated (or correlated) with Jasper Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jasper Therapeutics has no effect on the direction of Zymeworks Common i.e., Zymeworks Common and Jasper Therapeutics go up and down completely randomly.

Pair Corralation between Zymeworks Common and Jasper Therapeutics

Given the investment horizon of 90 days Zymeworks Common Stock is expected to generate 0.47 times more return on investment than Jasper Therapeutics. However, Zymeworks Common Stock is 2.12 times less risky than Jasper Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Jasper Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  814.00  in Zymeworks Common Stock on August 14, 2025 and sell it today you would earn a total of  991.00  from holding Zymeworks Common Stock or generate 121.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Zymeworks Common Stock  vs.  Jasper Therapeutics

Zymeworks Common Stock

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Zymeworks Common Stock are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent primary indicators, Zymeworks Common exhibited solid returns over the last few months and may actually be approaching a breakup point.

Jasper Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Jasper Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Zymeworks Common and Jasper Therapeutics

The main advantage of trading using opposite Zymeworks Common and Jasper Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zymeworks Common position performs unexpectedly, Jasper Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jasper Therapeutics will offset losses from the drop in Jasper Therapeutics' long position.

The idea behind Zymeworks Common Stock and Jasper Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.